Literature DB >> 3094717

Nifedipine in the treatment of chilblains.

P M Dowd, M H Rustin, S Lanigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3094717      PMCID： PMC1341713          DOI： 10.1136/bmj.293.6552.923-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Chilblains.

Authors:  R B LYNN
Journal:  Surg Gynecol Obstet       Date:  1954-12

2.  The problem of chilblains with a note on their treatment with nicotinic acid.

Authors:  R J GOURLAY
Journal:  Br Med J       Date:  1948-02-21

3.  Perniosis: a histopathological review.

Authors:  L M Wall; N P Smith
Journal:  Clin Exp Dermatol       Date:  1981-05       Impact factor: 3.470

4.  Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.

Authors:  C D Smith; R J McKendry
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321
  4 in total
  6 in total

1.  Pernio (chilblains).

Authors:  Amjad Almahameed; Duane S Pinto
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04

2.  Perniosis (chilblains) masquerading as CA-MRSA: a case report.

Authors:  Keith D Bohman; Thomas J Papadimos; Lorie D Gottwald; Zhixing K Pan
Journal:  Cases J       Date:  2009-05-29

Review 3.  Chilblains in Southern California: two case reports and a review of the literature.

Authors:  Rebecca Gordon; Anne M Arikian; Anita S Pakula
Journal:  J Med Case Rep       Date:  2014-11-22

4.  Chilblains in immune mediated inflammatory diseases: a review.

Authors:  Shirish Dubey; Nilay Joshi; Olivia Stevenson; Caroline Gordon; John A Reynolds
Journal:  Rheumatology (Oxford)       Date:  2022-04-12       Impact factor: 7.046

5.  Pharmacologic Treatment of Idiopathic Chilblains (Pernio): A Systematic Review.

Authors:  Michelle Pratt; Farhan Mahmood; Mark G Kirchhof
Journal:  J Cutan Med Surg       Date:  2021-03-02       Impact factor: 2.092

6.  "COVID Toes" in Three Siblings.

Authors:  Henry M Feder
Journal:  Pediatr Infect Dis J       Date:  2021-12-01       Impact factor: 3.806
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.